Profiel
Paul R.
McGuirk is currently Director, Chief Development Officer & Executive VP at Gardiner Healthcare Acquisitions Corp.
since 2021.
He is Chief Development Officer & Executive VP at Gardiner Founder LLC.
He is an Authorized Member at PRM Pharmaceuticals LLC.
Formerly, Dr. McGuirk was Executive Director at Chemical Technologies, Inc. He was Chief Technology Officer, Director & EVP at Aeromics, Inc. from 2009 to 2020.
He was Manager-Infectious Diseases Medicinal Chemistry at Pfizer Inc. from 1982 to 2009.
Actieve functies van Paul R. McGuirk
| Bedrijven | Functie | Begin |
|---|---|---|
| GARDINER HEALTHCARE ACQUISITIONS CORP. | Directeur/Bestuurslid | 01-04-2021 |
PRM Pharmaceuticals LLC | Corporate Officer/Principal | - |
Gardiner Founder LLC | Corporate Officer/Principal | - |
Eerdere bekende functies van Paul R. McGuirk
| Bedrijven | Functie | Einde |
|---|---|---|
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Hoofd Techniek/Wetenschap/O&O | 01-11-2020 |
| PFIZER INC. | Corporate Officer/Principal | 01-01-2009 |
Chemical Technologies, Inc.
Chemical Technologies, Inc. Contract DrillingIndustrial Services Provides retail drilling fluids services | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Chemical Technologies, Inc.
Chemical Technologies, Inc. Contract DrillingIndustrial Services Provides retail drilling fluids services | Industrial Services |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Health Technology |
Gardiner Healthcare Acquisitions Corp.
Gardiner Healthcare Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Gardiner Founder LLC | |
PRM Pharmaceuticals LLC |
















